"As I said before, we're delivering on all of our promises
"As I said before, we're delivering on all of our promises ..."
That's all that really needs to be said!
I have had zero doubt.
From my first email with Rory, to the first time I met him and Jeff and the original handful of #teamVERB employees.
I knew then and never thought twice.
So, all the noise and fake concerns and second guessing the armchair basement CO'S that needed answers to evn the most recent how dare they do this or that, not once did I have concern.
Because I knew that my payoff would be greater than ever imagined. I was in for success. Not a dollar.
And as this team grew and brought on people that worked like the rest of the team it only was more inevitable that success took on a larger and more worldwide scale meaning.
World Domination was talked about a long time ago, buy it's not done from a 3 room office with 5 people.
Ot was always gonna take growth and sometimes painful ones.
The foundation that is still being laid is phenomenal. The transcript spells it out and it's still just a portion of what's coming.
So back to what Rory talked about about...
Salesforce
Integrated & Announced
Microsoft
"we intend that Microsoft will be the next one we announce. So standby."
Not just grouth, but
" hyper growth"
Worldwide growth
"Japan operations are continuing to perform very well, in fact, I believe we launched another new client just this week."
Verb Ecosystem
"We're also making progress on our own app store ecosystem.."
More acquisitions
"we recently executed a letter of intent for another acquisition that will allow us to expand more rapidly into a desirable new business vertical products and services. Contracts are now out to review and when executed potentially, as soon as next week, we will disclose the full details for all of you in an SEC filing. If executed as we anticipate, the transaction is expected to close next month."
5 straight quarters of growth.
And from the start this was and is still the board only that supports Rory, Jeff and #teamVERB!
See saw through all the BS and didn't put up with it here.
The true Co-Owners feel a sense of pride. Not for blindly following anyone, but being a community that supported a team that supported us back.
What an incredible week!
It has that sensation of the road to the NASDAQ all over again.
It's looking fantastic from here.
Much Aloha and Mahalo to all those who have contributed in a positive manner.
It's going to be a blast.
15
TON Strategy Co. (TONX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...
Continue Reading
Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...
Continue Reading
Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...
Continue Reading
Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...
Continue Reading
Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...
Continue Reading
New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...
Continue Reading
Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...
Continue Reading
An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...
Continue Reading
BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...
Continue Reading
Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...
Continue Reading
Top 5 Most Recently Viewed Articles
Cobre del Mayo Launches Exchange Offer Cobre del Mayo, S.A. de C.V. ("CDM") has announced an exciting exchange offer aimed at providing opportunities for Eligible Holders. This initiative involves exchanging all outstanding Senior Secured PIK Toggle Notes due 2030 for new Senior Secured PIK Toggle Notes due in 2032. Understanding the Exchange Offer The exchange offer is...
Continue Reading
Remarkable Discovery of Michael Jordan Cards An extraordinary find of over 500 valuable Michael Jordan basketball cards has recently taken the sports world by storm. This discovery adds significant excitement to the sports card market, which has seen a resurgence in interest among collectors and enthusiasts alike. How the Collection Was Found The rare cards were unearthed...
Continue Reading
Foxconn's record third quarter performance hit the headlines back in 2024, with a staggering revenue of T$1.85 trillion ($57.3 billion). This marked a significant 20.2% surge from the previous year—one for the books, right? It not only eclipsed analyst estimates but also smashed Foxconn's own projections. You know these desks were buzzing after hearing those figures...
Continue Reading
Worlds Inc. Uplists to OTCQB for Enhanced Market Visibility Boston, MA — Worlds Inc. (OTCQB: WDDD) has reached an important milestone by moving up from the OTC Pink Market to the OTCQB Venture Market. This transition is set to improve trading visibility and liquidity, effective immediately. New Strategic Opportunities Ahead Thom Kidrin, the CEO of Worlds Inc., shared...
Continue Reading
Mercer International Inc. Reports Third Quarter 2024 Results Selected Highlights Operating EBITDA for Q3 rose by 35% to $50.5 million (net loss of $17.6 million), up from $37.5 million (net loss of $26.0 million) year-over-year. Strength noted in softwood pulp markets. Pulp production was affected by unplanned downtime events. Quarterly cash dividend announced at $0.075
Continue Reading